<p>Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature</p>-Reference-Cited by-同舟云学术

Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature

Published:2020-04 Issue: Volume:Volume 16 Page:111-123
ISSN:1178-2048
Container-title:Vascular Health and Risk Management
language:en
Short-container-title:VHRM

Author:

Matsuishi Yujiro,Mathis Bryan J^ORCID,Shimojo Nobutake,Kawano Satoru^ORCID,Inoue Yoshiaki

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Public Health, Environmental and Occupational Health,Hematology,General Medicine,Endocrinology, Diabetes and Metabolism

Reference87 articles.

1. Summary of product characteristics of Rapibloc. Available from: https://mri.cts-mrp.eu/Human/Downloads/NL_H_3368_002_FinalSPC.pdf. Accessed February 27, 2020.

2. AOP and AMOMED announce the launch of RAPIBLOC® (Landiolol) in Germany and Austria. Available from: https://www.amomed.com/aop-and-amomed-announce-the-launch-of-rapibloc-landiolol-in-germany-and-austria/?lang=en. 2017. Accessed February 27, 2020.

3. Approval for Corebeta ® for Injection 12. 5mg for Improvement of Image Quality in Coronary CT Angiography in Japan.

4. Approval for Additional Indication of Onoact ® 50 for injection, Short-Acting Selective β 1 Blocker in Japan. Available from: https://www.ono.co.jp/eng/news/pdf/sm_cn131122.pdf. 2013. Accessed January 25, 2020..

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation;Pharmaceutics;2024-04-08

2. Diagnosis and Treatment of New-Onset Perioperative Atrial Fibrillation;Advances in Anesthesia;2023-12

3. Optimal use of intravenous landiolol in acute cardiac care;Expert Review of Cardiovascular Therapy;2023-11-02

4. Hemodynamic and Rhythmologic Effects of Push-Dose Landiolol in Critical Care—A Retrospective Cross-Sectional Study;Pharmaceuticals;2023-01-17

5. Effect of landiolol in patients with tachyarrhythmias and acute decompensated heart failure (ADHF): a case series;ESC Heart Failure;2021-12-27